Insmed Incorporated · BX:IM8N

Insmed Incorporated financial statements

Insmed Incorporated's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue606.4M363.7M305.2M245.4M188.5M164.4M136.5M9.84M00
Cost of revenue122.9M85.7M65.6M55.1M44.2M39.9M24.2M2.42M00
Gross profit483.5M278.0M239.6M190.2M144.3M124.5M112.3M7.41M00
Research and development771.1M598.4M571.0M397.5M272.7M181.2M131.7M145.3M109.7M122.7M
Selling, general and administrative701.2M461.1M344.5M265.8M
Operating income-1.25B-878.3M-709.6M-457.3M-375.1M-265.2M-235.2M-307.3M-188.9M-173.4M
Depreciation and amortization10.4M5.96M5.50M5.30M9.10M9.10M5.20M3.60M2.90M2.40M
EBITDA-1.24B-872.3M-704.1M-452.0M-366.0M-256.1M-230.0M-303.7M-186.0M-171.0M
Interest expense83.8M84.9M81.7M26.4M40.5M29.6M27.7M25.5M5.92M3.50M
Income before tax-1.27B-910.1M-747.0M-480.2M-436.4M-292.7M-253.6M-324.1M-192.9M-176.2M
Income tax5.03M3.71M2.56M1.38M-1.76M1.40M777.0K201.0K-272.0K98.0K
Net income-1.28B-913.8M-749.6M-481.5M-434.7M-294.1M-254.3M-324.3M-192.6M-176.3M
Earnings per share, basic-6.42-5.57-5.34-3.91-3.88-3.01-3.01-4.22-2.89-2.85
Earnings per share, diluted-6.42-5.57-5.34-3.91-3.88-3.01-3.01-4.22-2.89-2.85

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents510.4M555.0M482.4M1.07B716.8M532.8M487.4M495.1M381.2M162.6M
Short-term investments919.6M878.8M298.1M74.2M0
Receivables140.9M52.0M41.2M29.7M24.4M16.6M19.2M5.51M0
Inventory132.1M98.6M83.2M69.9M67.0M49.6M28.3M7.03M0
Current assets1.79B1.62B929.1M1.27B837.0M622.9M555.2M518.9M389.4M168.4M
Property, plant and equipment102.9M80.1M65.4M56.5M53.0M54.0M60.2M22.6M12.4M10.0M
Goodwill136.1M136.1M136.1M136.1M136.1M0
Total assets2.26B2.03B1.33B1.66B1.24B796.2M742.3M604.6M462.0M238.0M
Accounts payable79.9M73.0M65.4M50.5M35.8M42.9M13.2M17.7M14.7M10.4M
Current liabilities468.9M297.5M225.6M190.2M135.2M118.8M85.2M79.7M44.7M28.0M
Long-term debt541.0M1.10B1.16B1.13B566.6M356.3M335.9M316.6M55.6M54.8M
Total debt546.8M1.12B1.18B1.15B800.0M450.0M450.0M450.0M55.0M55.0M
Total liabilities1.53B1.74B1.66B1.57B833.0M520.3M480.6M396.3M101.0M83.5M
Shareholders' equity739.0M285.4M-331.9M88.0M410.5M275.9M261.7M208.3M361.1M154.5M
Shares outstanding214.3M179.4M148.0M135.7M118.7M102.8M89.7M77.3M76.6M62.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-935.0M-683.9M-536.2M-400.4M-363.3M-219.3M-250.6M-258.0M-159.6M-146.7M
Capital spending-32.6M-21.9M-13.3M-9.88M-7.29M-6.24M-42.3M-13.1M-3.00M-4.20M
Free cash flow-967.6M-705.8M-549.5M-410.3M-370.6M-225.6M-292.9M-271.1M-162.6M-150.9M
Cash from investing-64.6M-583.2M-223.6M-34.6M-64.3M-6.82M-42.3M-14.8M-3.00M-4.20M
Cash from financing954.1M1.34B168.4M793.3M612.5M271.0M285.3M386.7M381.1M30.7M
Change in cash-44.6M72.7M-591.7M357.3M184.0M45.3M-7.64M113.9M218.6M-120.3M